Paul-Albert Koenig - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Paul-Albert Koenig

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Science Immunology|September 15, 2019

RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.

Immunity|October 4, 2016

K<sup>+</sup> Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting MitochondriaChristina J Groß, Ritu Mishra, Katharina S Schneider, et al.

Science (New York, N.Y.)|January 13, 2021

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escapePaul-Albert Koenig, Hrishikesh Das, Hejun Liu, et al.

Science (New York, N.Y.)|December 2, 2017

The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.

Immunity|September 30, 2021

Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Science Immunology|September 15, 2019

RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.

Immunity|October 4, 2016

K<sup>+</sup> Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting MitochondriaChristina J Groß, Ritu Mishra, Katharina S Schneider, et al.

Science (New York, N.Y.)|January 13, 2021

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escapePaul-Albert Koenig, Hrishikesh Das, Hejun Liu, et al.

Science (New York, N.Y.)|December 2, 2017

The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.

Immunity|September 30, 2021

Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.

Pageof 2